DarioHealth Corp. DRIO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -22.65% | -24.41% | -17.31% | 7.29% | 41.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.65% | -24.41% | -17.31% | 7.29% | 41.79% |
| Cost of Revenue | -2.56% | -3.98% | -8.24% | -12.41% | -3.80% |
| Gross Profit | -31.47% | -33.42% | -21.65% | 19.93% | 79.04% |
| SG&A Expenses | -11.46% | -17.22% | -22.94% | -20.77% | -18.03% |
| Depreciation & Amortization | -81.80% | -79.49% | -66.79% | -42.68% | -14.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.13% | -27.23% | -29.79% | -23.37% | -17.02% |
| Operating Income | 23.44% | 28.85% | 35.71% | 35.12% | 34.71% |
| Income Before Tax | 20.02% | 9.05% | 6.70% | 14.60% | 16.53% |
| Income Tax Expenses | 185.37% | -14.63% | 105.67% | 109.11% | 108.50% |
| Earnings from Continuing Operations | 19.26% | 9.07% | 2.42% | 10.73% | 13.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.26% | 9.07% | 2.42% | 10.73% | 13.04% |
| EBIT | 23.44% | 28.85% | 35.71% | 35.12% | 34.71% |
| EBITDA | 15.72% | 21.99% | 32.41% | 35.96% | 39.17% |
| EPS Basic | 74.42% | 1.88% | -93.47% | -36.30% | -16.22% |
| Normalized Basic EPS | 62.61% | 42.53% | 33.67% | 47.63% | 46.86% |
| EPS Diluted | 74.42% | 1.88% | -93.47% | -36.30% | -16.22% |
| Normalized Diluted EPS | 62.61% | 42.53% | 33.67% | 47.63% | 46.86% |
| Average Basic Shares Outstanding | 149.42% | 94.80% | 64.27% | 66.19% | 63.87% |
| Average Diluted Shares Outstanding | 149.42% | 94.80% | 64.27% | 66.19% | 63.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |